Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells

Biochemical Pharmacology

Volumn 56, Issue 2, 1998, Pages 197-206

  Ciolino, Henry P ^a,b   Daschner, Phillip J ^a   Wang, Thomas T Y ^a   Yeh, Grace Chao ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aryl hydrocarbon receptor; Curcumin; Cytochrome P450 1A1; Dimethylbenzanthracene; DNA adducts; MCF 7 cells

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CURCUMIN; CYTOCHROME P450 ISOENZYME; DIMETHYLBENZ[A]ANTHRACENE; UNSPECIFIC MONOOXYGENASE;

ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL PROTECTION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA ADDUCT; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANTICARCINOGENIC AGENTS; BIOTRANSFORMATION; BREAST NEOPLASMS; CARCINOGENS; CURCUMIN; CYTOCHROME P-450 CYP1A1; DNA-BINDING PROTEINS; HUMANS; PROTEIN BINDING; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TUMOR CELLS, CULTURED;

EID: 0031725843     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00143-9     Document Type: Article

References (32)

1. Poland A and Knutson JC, Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22: 517-554, 1982.
2. Hankinson O, The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35: 307-340, 1995.
3. Dipple A, Reactions of polycyclic aromatic hydrocarbon carcinogens. IARC Sci Publ 125: 107-129, 1994.
4. Gillner M, Bergman J, Cambillau C, Fernstrom B and Gustafsson J, Interactions of indoles with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol Pharmacol 28: 357-363, 1985.
5. Ammon HPT and Wahl MA, Pharmacology of Curcuma longa. Planta Med 57: 1-7, 1991.
6. Rao CV, Rivenson A, Simi B and Reddy BS, Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55: 259-266, 1995.
7. Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana J, Whitaker LM, Kelloff GJ, Steele VE and Lubet RA, Effect of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17: 1305-1311, 1996.
8. Huang MT, Ma W, Lu YP, Chang RL, Fisher C, Manchand PS, Newmark HL and Conney AH, Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16: 2493-2497, 1995.
9. Limtrakul P, Lipigorngoson S, Namwong O, Apisariyakul A and Dunn FW, Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 116: 197-203, 1997.
10. Singletary K, MacDonald C, Wallig M and Fisher C, Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 103: 137-141, 1996.
11. Oetari S, Sudibyo M, Commandeur JN, Samhoedi R and Vermeulen NP, Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol 51: 39-45, 1996.
12. Deshpande SS and Maru GB, Effects of curcumin on the formation of benzo[a]pyrene derived DNA adducts in vitro. Cancer Lett 96: 71-80, 1995.
13. 1. Chem Biol Interact 100: 41-51, 1996.
14. Wang X, Thomsen JS, Santostefano M, Rosengren R, Safe S and Perdew GH, Comparative properties of the nuclear aryl hydrocarbon (Ah) receptor complex from several human cell lines. Eur J Pharmacol 293: 191-205, 1995.
15. Dohr O, Vogel C and Abel J, Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Arch Biochem Biophys 321: 405-412, 1995.
16. Moore M, Wang X, Lu Y-F, Wormke M, Craig A, Gerlach JH, Burghardt R, Barhoumi R and Safe S, Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone. J Biol Chem 269: 11751-11759, 1994.
17. Chomczynski P and Sacchi N, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
18. Denison MS, Fisher JM and Whitlock JP Jr, The DNA recognition site for the dioxin-Ah receptor complex: Nucleotide sequence and functional analysis. J Biol Chem 263: 17221-17224, 1988.
19. Chen Y-H and Tukey RH, Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J Biol Chem 271: 26261-26266, 1996.
20. Poellinger L, Lund J, Dahlberg E and Gustafsson JA, A hydroxylapatite microassay for receptor binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene in various target tissues. Anal Biochem 144: 371-384, 1985.
21. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
22. Kennedy SW and Jones SP, Simultaneous measurement of cytochrome P4501A catalytic activity and total protein concentration with a fluorescence plate reader. Anal Biochem 222: 217-223, 1994.
23. Miller SA, Dykes DD and Polesky HF, A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
24. Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero DA, Monks A and Boyd MR, Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 82: 1113-1118, 1990.
25. Christou M, Savas U, Spink DC, Gierthy JF and Jefcoate CR, Co-expression of human CYP1A1 and a human analog of cytochrome P450-EF in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells. Carcinogenesis 15: 725-732, 1994.
26. Rowlands JC and Gustafsson JA, Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 27: 109-134, 1997.
27. Sharma OP, Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 25: 1811-1812, 1976.
28. Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD and Conney AH, Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51: 813-819, 1991.
29. Bierhaus A, Zhang Y, Quehenberger P, Luther T, Haase M, Müller M, Mackman N, Ziegler R and Nawroth PP, The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB. Thromb Haemost 77: 772-782, 1997.
30. Kuo ML, Huang TS and Lin JK, Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317: 95-100, 1996.
31. Dzeletovic N, McGuire J, Daujat M, Tholander J, Ema M, Fujii-Kuriyama Y, Bergman J, Maurel P and Poellinger L, Regulation of dioxin receptor function by omeprazole. J Biol Chem 272: 12705-12713, 1997.
32. Washburn BS, Rein KS, Baden DG, Walsh PJ, Hinton DE, Tullis K and Denison MS, Brevetoxin-6 (PbTx-6), a nonaromatic marine neurotoxin, is a ligand of the aryl hydrocarbon receptor. Arch Biochem Biophys 343: 149-156, 1997.